Rainbow Children's Medicare Limited
NSE: RAINBOW BSE: RAINBOW
Prev Close
1138.1
Open Price
1150
Volume
125,478
Today Low / High
1136.5 / 1158.1
52 WK Low / High
1136.5 / 1645.7
Range
1,087 - 1,202
Prev Close
1137.3
Open Price
1145.3
Volume
4,161
Today Low / High
1136.75 / 1156.5
52 WK Low / High
1123.5 / 1644.1
Range
1,090 - 1,205
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 1144.4 (target range: 1,087 - 1,202), reflecting a change of 6.3 (0.55355%). On the BSE, it is listed at 1147.4 (target range: 1,090 - 1,205), showing a change of 10.1 (0.88807%). Both the NSE and BSE data indicate positive movement, suggesting the stock is on an upward trend. This could be an attractive opportunity for investors looking for growth.
Rainbow Children's Medicare Limited Graph
Rainbow Children's Medicare Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Rainbow Children's Medicare Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 1,144.40, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 1,147.40 | 1,158.87 | 1,042.99 - 1,274.76 |
| 1,170.35 | 936.28 - 1,404.42 | ||
| 1,181.82 | 827.28 - 1,536.37 | ||
| Bearish Scenario | 1,147.40 | 1,135.93 | 1,022.33 - 1,249.52 |
| 1,124.45 | 899.56 - 1,349.34 | ||
| 1,112.98 | 779.08 - 1,446.87 |
Overview of Rainbow Children's Medicare Limited
ISIN
INE961O01016
Industry
Medical - Care Facilities
Vol.Avg
130,720
Market Cap
116,224,302,704
Last Dividend
3
Official Website
IPO Date
2022-05-10
DCF Diff
77.47
DCF
1,052
Financial Ratios Every Investor Needs
Stock Dividend of RAINBOW
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2025-06-27 | June 27, 25 | 3 | 3 | 2025-06-28 | 2025-08-04 | |
| 2024-07-23 | July 23, 24 | 3 | 3 | 2024-07-23 | 2024-08-29 | |
| 2023-06-22 | June 22, 23 | 3 | 3 | 2023-06-22 | 2023-07-29 | |
| 2022-09-07 | September 07, 22 | 2 | 2 | 2022-09-08 | 2022-10-15 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 1,515.87 Cr | 434.06 Cr | 1,081.81 Cr | 0.7137 | 0.00 Cr | 19.47 Cr | 679.42 Cr | 243.42 Cr | 23.97 | 437.45 Cr | 0.1606 |
| 2024-03-31 | 1,296.90 Cr | 366.25 Cr | 930.65 Cr | 0.7176 | 0.00 Cr | 305.37 Cr | 594.63 Cr | 217.00 Cr | 21.38 | 389.74 Cr | 0.1673 |
| 2023-03-31 | 1,173.57 Cr | 330.00 Cr | 843.57 Cr | 0.7188 | 0.00 Cr | 13.34 Cr | 541.75 Cr | 210.83 Cr | 20.89 | 365.04 Cr | 0.1797 |
| 2022-03-31 | 973.76 Cr | 329.76 Cr | 644.00 Cr | 0.6614 | 0.00 Cr | 213.70 Cr | 417.24 Cr | 138.27 Cr | 14.75 | 273.15 Cr | 0.1420 |
| 2021-03-31 | 650.05 Cr | 225.60 Cr | 424.45 Cr | 0.6530 | 0.00 Cr | 3.21 Cr | 412.19 Cr | 40.02 Cr | 4.36 | 134.57 Cr | 0.0616 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 20.28 Cr | 2,376.99 Cr | 901.98 Cr | 1,468.1930 Cr | 763.58 Cr | 743.31 Cr | 27.57 Cr | 1,415.58 Cr | 0.00 Cr | 0.00 Cr | 32.22 Cr | 150.5720 Cr |
| 2024-03-31 | 10.12 Cr | 2,170.40 Cr | 905.48 Cr | 1,258.9270 Cr | 765.31 Cr | 755.19 Cr | 23.98 Cr | 1,262.69 Cr | 3.94 Cr | -170.06 Cr | -124.79 Cr | 149.4530 Cr |
| 2023-03-31 | 15.41 Cr | 1,776.30 Cr | 705.81 Cr | 1,059.9110 Cr | 570.32 Cr | 554.91 Cr | 18.76 Cr | 948.62 Cr | 3.28 Cr | -124.90 Cr | 259.30 Cr | 138.8680 Cr |
| 2022-03-31 | 9.98 Cr | 1,424.00 Cr | 689.48 Cr | 602.8040 Cr | 579.05 Cr | 569.08 Cr | 14.82 Cr | 874.88 Cr | 9.10 Cr | 0.00 Cr | 79.87 Cr | 125.1870 Cr |
| 2021-03-31 | 5.66 Cr | 1,081.27 Cr | 632.89 Cr | 446.3630 Cr | 518.47 Cr | 512.82 Cr | 10.10 Cr | 796.56 Cr | 51.65 Cr | 0.00 Cr | 23.50 Cr | 122.0780 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 395.6580 Cr | -267.7980 Cr | -117.7240 Cr | 249.9880 Cr | 10.1360 Cr | 20.2550 Cr | -145.6700 Cr | 243.4240 Cr | -87.3100 Cr | -30.4640 Cr | -3.5910 Cr |
| 2024-03-31 | 321.4010 Cr | -226.4660 Cr | -101.7810 Cr | -32.1750 Cr | -6.8460 Cr | 10.1260 Cr | -353.5760 Cr | 217.0010 Cr | -72.4990 Cr | -30.7520 Cr | -5.2180 Cr |
| 2023-03-31 | 327.2260 Cr | -465.2000 Cr | 143.4050 Cr | 185.9300 Cr | 5.4310 Cr | 15.4100 Cr | -141.2960 Cr | 281.7790 Cr | -39.8110 Cr | -20.2930 Cr | -3.9370 Cr |
| 2022-03-31 | 223.7280 Cr | -175.3450 Cr | -44.0620 Cr | 161.5030 Cr | 4.3210 Cr | 9.9790 Cr | -62.2250 Cr | 187.3460 Cr | -6.0720 Cr | -9.2480 Cr | -4.7260 Cr |
| 2021-03-31 | 142.7140 Cr | -82.8800 Cr | -60.8730 Cr | 66.6110 Cr | -1.0390 Cr | 5.6580 Cr | -76.1030 Cr | 55.6960 Cr | -9.4710 Cr | 0.0000 Cr | 5.8800 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | 445.45 Cr | 268.06 Cr | 177.39 Cr | 0.3982 | 107.38 Cr | 72.53 Cr | 7.14 | 157.49 Cr | 0.1628 |
| 2025-09-30 | 444.80 Cr | 263.15 Cr | 181.65 Cr | 0.4084 | 113.02 Cr | 75.25 Cr | 7.41 | 157.06 Cr | 0.1692 |
| 2025-06-30 | 352.93 Cr | 225.06 Cr | 127.87 Cr | 0.3623 | 69.44 Cr | 53.50 Cr | 5.27 | 123.64 Cr | 0.1516 |
| 2025-03-31 | 370.11 Cr | 134.13 Cr | 235.98 Cr | 0.6376 | 108.16 Cr | 56.34 Cr | 5.55 | 102.07 Cr | 0.1522 |
| 2024-12-31 | 398.08 Cr | 103.03 Cr | 295.05 Cr | 0.7412 | 200.68 Cr | 68.69 Cr | 6.76 | 116.64 Cr | 0.1725 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 26.84 Cr | 415.53 Cr | 442.36 Cr | 110.83 Cr | 40.34 Cr | 727.79 Cr | 1,504.11 Cr | 2,586.65 Cr | 1,053.72 Cr |
| 2025-06-30 | 0.00 Cr | 0.00 Cr | 693.60 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -1,475.01 Cr |
| 2025-03-31 | 20.26 Cr | 673.34 Cr | 693.60 Cr | 77.30 Cr | 27.57 Cr | 822.05 Cr | 1,415.58 Cr | 2,376.99 Cr | 901.98 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 450.46 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -1,349.75 Cr |
| 2024-09-30 | 27.35 Cr | 423.11 Cr | 450.46 Cr | 94.86 Cr | 27.99 Cr | 685.44 Cr | 1,420.10 Cr | 2,261.93 Cr | 912.18 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 53.50 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2025-03-31 | 56.34 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | 68.69 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 78.87 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 39.53 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Medical - Care Facilities
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Apollo Hospitals Enterprise Limited | APOLLOHOSP | ₹6,948.00 | ₹999,015,796,836.00 | ₹255,106.00 |
| Max Healthcare Institute Limited | MAXHEALTH | ₹976.70 | ₹950,330,076,700.00 | ₹4,000,115.00 |
| Fortis Healthcare Limited | FORTIS | ₹832.80 | ₹628,729,145,654.00 | ₹364,148.00 |
| Narayana Hrudayalaya Limited | NH | ₹1,801.90 | ₹365,965,592,687.00 | ₹172,481.00 |
| Global Health Limited | MEDANTA | ₹1,120.10 | ₹301,072,093,437.00 | ₹712,234.00 |
| Aster DM Healthcare Limited | ASTERDM | ₹570.40 | ₹294,860,600,134.00 | ₹414,774.00 |
| Krishna Institute of Medical Sciences Limited | KIMS | ₹593.55 | ₹237,502,464,869.00 | ₹204,888.00 |
| Rainbow Children's Medicare Limited | RAINBOW | ₹1,144.40 | ₹116,224,302,704.00 | ₹125,478.00 |
| Jupiter Life Line Hospitals Limited | JLHL | ₹1,307.60 | ₹85,734,130,367.00 | ₹30,535.00 |
| HealthCare Global Enterprises Limited | HCG | ₹593.30 | ₹83,659,825,692.00 | ₹122,575.00 |
| Yatharth Hospital & Trauma Care Services Limited | YATHARTH | ₹610.15 | ₹58,790,610,924.00 | ₹407,727.00 |
| Artemis Medicare Services Limited | ARTEMISMED | ₹246.52 | ₹38,719,295,499.00 | ₹210,325.00 |
| Kovai Medical Center and Hospital Limited | KOVAI | ₹2,581.00 | ₹35,290,787,300.00 | ₹5,780.00 |
| Indraprastha Medical Corporation Limited | INDRAMEDCO | ₹370.95 | ₹34,006,099,350.00 | ₹176,994.00 |
Key Executives
Gender: Not Specified
Year Born: 1969
Gender: Not Specified
Year Born: 1961
Gender: male
Year Born: 1966
Gender: male
Year Born:
Gender: male
Year Born:
Gender: female
Year Born: 1994
FAQs about Rainbow Children's Medicare Limited
The CEO is Abrarali Dalal.
The current price is ₹1,144.40.
The range is ₹1136.5-1645.7.
The market capitalization is ₹11,622.43 crores.
The dividend yield is 0.26%.
The P/E ratio is 45.12.
The company operates in the Healthcare sector.
Overview of Rainbow Children's Medicare Limited (ISIN: INE961O01016) is a leading Medical - Care Facilities in India. With a market capitalization of ₹11,622.43 crores and an average daily volume of 130,720 shares, it operates in the Medical - Care Facilities. The company last declared a dividend of ₹3.